FDA Panel Supports Lower Acetaminophen Dose But Spares Combo Products

In what could be a major blow to manufacturers, acetaminophen sold in 500 mg tablets will come off the OTC market if FDA follows a joint advisory committee's recommendations, but the industry may be spared the additional pain of losing combination products that include acetaminophen and other ingredients.

More from Archive

More from Pink Sheet